gadobenate (Multihance) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Gadobenic acid is a complex of gadolinium with the ligand BOPTA. In the form of the methylglucamine salt meglumine gadobenate (INNm) or gadobenate dimeglumine (USAN), it is used as a gadolinium-based MRI contrast medium.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$6.4300 - $113.1860
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

3,6,9-triaza-12-oxa-3,6,9-tricarboxymethylene-10-carboxy-13-phenyltridecanoic acid, gadolinium | acide gadobenique | acido gadobenico | acidum gadobenicum | altana pharma brand of gadobenic acid, dimeglumine salt | b 19036 | b-19036 | b1903617 | gadobenate | gadobenate dimeglumine | gadobenic acid | gadobenic acid, dimeglumine salt | gadobensäure | gadolinium-benzyloxypropionyl tetraacetate | gadolinium-bopta-dimeg | gd-bopta | gd(bopta)2 | multihance | multihance multipack

Organizations (15)

Research & Development (15)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (20)

Approved Indications (1)


 

Diagnostic Imaging (approved 2004)

Experimental Indications - Clinical Trial Phases 1-4 (19)


 

Aortic Diseases (Phase 3)

Arterial Occlusive Diseases (Phase 3)

Brain Diseases (Phase 4)

Brain Neoplasms (Phase 4)

Breast Neoplasms (Phase 3)

Carcinoma, Intraductal, Noninfiltrating (Phase 2)

Central Nervous System Diseases (Phase 3)

Cognition (Phase 4)

Colorectal Neoplasms (Phase 4)

Contrast Media (Phase 4)

Glioma (Early Phase 1)

Heart Failure (Early Phase 1)

Hypertrophy, Left Ventricular (Early Phase 1)

Lymphoma (Early Phase 1)

Motor Activity (Phase 4)

Myocardial Infarction (Early Phase 1)

Neoplasm Metastasis (Phase 4)

Peripheral Vascular Diseases (Phase 3)

Prostatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 23
  • # of Trial Organizations: 15

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue